Evolving indications for tricuspid valve surgery

Patrick M McCarthy1, Virna L Sales

  • 1Division of Cardiac Surgery, Feinberg School of Medicine, Northwestern University, 201 East Huron Street, Suite 11-140, Chicago, IL, 60611-2908, USA, pmccart@nmh.org.

Insights

Guidelines for tricuspid valve (TV) surgery remain unclear, especially for less severe regurgitation (TR) or when not combined with mitral valve surgery. Recent publications offer improved guidance for TV repair and replacement decisions.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Guidelines

Background:

  • The tricuspid valve (TV) receives less attention than the mitral valve (MV), leading to ambiguity in surgical timing for tricuspid regurgitation (TR).
  • Existing guidelines present areas of agreement, disagreement, and silence regarding TV surgery indications.

Purpose of the Study:

  • To review current guidelines (ACC/AHA, ESC) for tricuspid valve surgery.
  • To clarify decision-making for tricuspid regurgitation (TR) management, particularly in the context of mitral valve surgery and other clinical scenarios.
  • To synthesize recent evidence on tricuspid valve repair and replacement outcomes.

Main Methods:

  • Comparative analysis of American College of Cardiology/American Heart Association and European Society of Cardiology guidelines.
  • Review of recent scientific literature on tricuspid valve surgery outcomes.
  • Expert opinion synthesis from Northwestern University regarding guideline interpretation and application.

Main Results:

  • Guidelines show concordance for severe TR during MV surgery.
  • Discordance exists for less severe TR with recurrence risk factors (e.g., pulmonary hypertension, atrial fibrillation).
  • Guidelines are silent on TR in patients undergoing non-MV operations, and primary TR surgery indications require further clarification.

Conclusions:

  • Current guidelines offer partial clarity on tricuspid valve surgery timing, especially in complex cases.
  • Emerging data on TV repair and replacement are crucial for refining surgical decision-making.
  • Further research and guideline refinement are needed for optimal management of tricuspid regurgitation.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...